The Distribution Pattern of Acinetobacter baumannii Isolated from Two Tertiary Health Institutions in Rivers State, Nigeria
Asian Journal of Research in Infectious Diseases,
The ubiquitous nature of Acinetobacter baumannii has made the Gram-negative, non-motile bacterium to be associated with hospital-acquired infection at the global level, and with respect to antimicrobial resistance, it has been categorized among the most dangerous multiple drug-resistant (MDR) pathogens globally and enlisted in the "priority 1: critical" pathogens list of the World Health Organization, existing in-hospital patients and environment. Many clinical manifestations such as pneumonia, and wound infection have posed a huge disease burden with massive economic loss. The infection is associated with high morbidity and mortality rates. The burden of this hospital pathogen demands attention, especially with the surge in the resistant strains distribution. In the area of this study, distribution patterns have not extensively been studied therefore, the research focused on the distribution pattern of hospital isolated Acinetobacter baumannii from selected tertiary health facilities in Rivers State Nigeria. The observational study involved isolation and biochemical identification, as well as molecular assay, which was performed using standardized methods, was conducted in two main tertiary hospitals located in Port Harcourt metropolis, Rivers State, Nigeria. Statistics were performed for percentage and frequency distribution. Kruskal-Wallis and Mann-Whitney tests were used to compare the difference in distribution at a 0.05 level of significance. Statistical Package for Social Science version 21 was used for the statistics.368 samples from two institutions; RSUTH 185 (50.3%) and UPTH 183 (49.7%). Females 187 (50.8%) were more compared to the males 181(49.2%) with a significant difference (p<0.05) in isolate distribution but no statistically significant difference (p>0.05) for location and sample. Also, sample distribution was uneven 59 (16.0%), 202 (54.9%), and 107 (29.1%) for aspirate, urine, and wound respectively. 2.4% was recorded in the preliminary investigation while a 75% positive rate was observed using the molecular method. Evidence of the presence of Acinetobacter baumannii in the hospital was established. Also, Acinetobacter baumanii was not isolated from the aspirate sample however, this is subject to further investigation with an increased sample size. Female subjects had a higher rate. The information obtained here is essential to guide therapeutics and the management of targeted clinical manifestation. Therefore, the study serves as surveillance of A. baumannii found in the selected region.
- Distribution pattern
- Acinetobacter baunmanni
- tertiary health facilities
- Rivers State
How to Cite
Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2010;55:1619–1629.
Guckan R, Kilinc C, Capraz A, Yanik K. Antimicrobial susceptibility of Acinetobacter baumannii complex isolated from different clinical samples in a tertiary care hospital. J Antibiot Res. 2015;1:1-5.
Akalin H, Sinirta M, Ocakolu G, Yilmaz E, Heper Y, Kelebek N et al. Nosocomial Acinetobacter pneumonia: treatment and prognostic factors in 356 cases. Respirology. 2016 Feb;21(2):363-9. Epub 2015 Dec 3.
Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens. 2021;10:373.
Patwardhan RB, Dhakephalkar PK, Niphadkar KB, Chopade BA. A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids. Indian J Med Res. 2008;128:178–187.
Seifert H, Stefanik D, Wisplinghoff H. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates. J Antimicrob Chemother. 2006;58:1099–1100.
Rodloff AC, Dowzicky MJ. Antimicrobial susceptibility among European Gram-negative and Gram-positive isolates collected as part of the Tigecycline Evaluation and Surveillance Trial (2004–2014) Chemotherapy. 2017;62:1–11.
Graser Y, Klare I, Halle E, Gantenberg R, Buchholz P, Jacobi H.D, Presber W, Schonian G. Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting. J. Clin. Microbiol. 1993; 31:2417–2420.
Seifert H, Baginski R, Schulze A, Pulverer G. The distribution of Acinetobacter species in clinical culture materials. Zent. Bakteriol. Int. J. Med Microbiol. 1993; 279:544–552.
Seifert H, Baginski R. The clinical significance of Acinetobacter baumannii in blood cultures. Zent. Bakteriol. Int. J. Med Microbiol. 1992;277:210– 218.
Antunes LC, Visca P, Towner KJ, et al. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014;71:292-301.
Ayenew Z, Tigabu E, Syoum E, Ebrahim S, Assefa D, Tsige E. Multidrug resistance pattern of Acinetobacter species isolated from clinical specimens referred to the Ethiopian Public Health Institute: 2014 to 2018 trend anaylsis. PLoS ONE. 2021; 16(4):e0250896.
Bashir, A, Adamu Almustapha Alier, Abdurrazak Muhammad Idris, Hamisu Umar Takalmawa, Sarkinfada Faruk, Agwu Ezera. Molecular characterization of Acinetobacter baumannii from patients with prolonged hospital stays in three tertiary hospitals of Kano Metropolis, Northwestern Nigeria. African Journal of Microbiology Research. 2019;13(27):510-517.
Nwadike VU, Ojide CK, Kalu EI. Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a nigerian tertiary hospital ICU. Afr J Infect Dis. 2014;8(1):14-8. PMID: 24653812; PMCID: PMC3957209.
Xie R, Zhang XD, Zhao Q, Peng B, Zheng J. Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries. Emerging Microbes & Infections. 2018;7(1):31. pmid:29535298
Kessaris A, Kravaritt M, Postolopoulou O, Bakola D, Sfiras D. The incidence of infections caused by multi-drug resistant Acinetobacter baumannii. ICU. 2006; 19:232–236.
Lul R, Smilja K, Zrinka B, Ana B, Stjepan K, Dubravko Š, Gjyle Mulliqi O. Molecular epidemiology of Acinetobacter baumannii in Central Intensive Care Unit in Kosova Teaching Hospital. BJID. 2009;13:408–413.
Oberoi A, Aruna A, Madan L. A Decade of an Underestimated Nosocomal Pathogen-Acinetobacter in a Tertiary Care Hospital in Punjab. JK Science. 2009;11:24–26
Iregbu KC, Ogunsola FT, Odugbemi TO. Infections caused by Acinetobacter spp and their susceptibility to 14 antibiotics in Lagos University Teaching Hospital, Lagos. West Afr J Med. 2002;21:226– 229.
Mushtaq S, Javeid I, Hassan M. Antibiotic sensitivity pattern of Acinetobacter species isolated from clinical specimens in a tertiary care hospital. Biomed Res. 2013; 29:23-6.
Altun HU, Yagci S, Bulut C, Sahin H, Kinikli S, Adiloglu K et al. Antimicrobial susceptibilities of clinical Acinetobacter baumannii isolates with different genotypes. Jundishapur J Microbiol. 2014 Dec 7;7(12):e13347.
Awad E, Osman I, El N, El M. High prevalence of multidrug-resistant Acinetobacter species in Khartoum Intensive Care Units (ICUs). Am J Res Commun. 2015;3(2):35-42.
Victor Moses Musyoki, Moses Muia Masika, Winnie Mutai, Gitau Wilfred, Antony Kuria, Felista Muthini. Antimicrobial susceptibility pattern of Acinetobacter isolates from patients in Kenyatta National Hospital, Nairobi, Kenya. Pan Africn Medical Journal. 2019;33:146,
Abstract View: 73 times
PDF Download: 22 times